E2 ModerateModerate confidencePEM unclearObservationalPeer-reviewedMachine draft
Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
Cameron, Barbara, Flamand, Louis, Juwana, Hedy et al. · Journal of medical virology · 2010 · DOI
Quick Summary
Researchers tested blood samples from ME/CFS patients and healthy controls to see whether three common herpesviruses (EBV, CMV, and HHV-6) were actively reactivating or causing ongoing infection. They found no evidence that these viruses were actively infected or reactivating in ME/CFS patients compared to controls who recovered normally from infection.
Why It Matters
For decades, researchers have investigated whether herpesviruses drive ME/CFS pathology. This well-designed longitudinal study from a prospective infection cohort provides direct evidence addressing a common hypothesis, helping narrow the focus of future mechanistic research toward other potential drivers of post-infectious fatigue.
Observed Findings
- All patients were seropositive for HHV-6; 10 of 20 were CMV seropositive at baseline.
- HHV-6 IgG antibody titers were highest at infection baseline and did not differ between CFS cases and control patients.
- EBV-specific antibody titers (VCA p18, EBNA-1, and EA) increased over time but showed no differences between CFS and control groups.
- CMV and HHV-6 DNA were detectable in only a minority of samples and at control levels; CMV DNA was undetectable in all samples.
Inferred Conclusions
- Ongoing or reactivated EBV, HHV-6, and CMV infection does not appear to be a primary mechanism in the pathogenesis of CFS.
- Herpesvirus seropositivity and antibody responses are similar in patients who develop CFS and those who recover normally from acute infection.
- Active viral replication (as measured by serology and PCR) is not a distinguishing feature of the post-infectious fatigue syndrome phenotype.
Remaining Questions
- Do herpesviruses play a role in tissue compartments not sampled by serum, or do they contribute to immune dysregulation without active replication?
- Could other viral agents—not tested in this study—be involved in post-infectious fatigue syndrome?
- Do the serological and molecular findings differ in later stages of ME/CFS, beyond the acute post-infection window studied here?
What This Study Does Not Prove
This study does not prove that herpesviruses play no role in ME/CFS under any circumstances—it only demonstrates that ongoing or reactivated herpesvirus infection is not present in serum at detectable levels during the acute phase studied. It does not rule out past herpesvirus infection as a trigger, latent viral persistence in tissue compartments, or viral contributions to immune dysregulation that persists after viral clearance.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Phenotype:Infection-Triggered
Method Flag:Small SampleExploratory Only
Metadata
- DOI
- 10.1002/jmv.21873
- PMID
- 20827765
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →